Maturitas
Volume 61, Issue 1 , Pages 17-26 , September 2008

“Reprint of” Testosterone enhances estradiol’s effects on postmenopausal bone density and sexuality

  • Susan R. Davis

      Affiliations

    • Corresponding Author InformationCorresponding author.
    • Prince Henry’s Institute of Medical Research, 246 Clayton Road, Clayton, Victoria 3168, Australia
    • ,
  • Philip McCloud

      Affiliations

    • Monash University, Clayton, Victoria 3168, Australia
    • ,
  • Boyd J.G. Strauss

      Affiliations

    • Body Composition Laboratory, Monash Medical Centre, 246 Clayton Road, Clayton, Victoria 3168, Australia
    • ,
  • Henry Burger

      Affiliations

    • Prince Henry’s Institute of Medical Research, 246 Clayton Road, Clayton, Victoria 3168, Australia

References 

  1. Mazess RB, Gallagher JC, Notelovitz M, Schiff I, Utian W. Monitoring skeletal response to estrogen. Am J Obstet Gynecol. 1989;843–848
  2. Need AG, Horowitz M, Bridges A, Morris AH, Nordin SEC. Effects of nandrolone decanoate and antiresorptive therapy on vertebral density in osteoporotic postmenopausal women. Arch Intern Med. 1989;149:57–60
  3. Sawas M, Studd JWW, Fogelman I, Dooley M, Montgomery J, Murby L. Skeletal effects of oral estrogen compared with subcutaneous estrogen and testosterone in postmenopausal women. Br Med J. 1988;297:331–333
  4. Garnett T, Studd J, Watson N, Sawas M, Leather A. The effects of plasma estradiol levels on increases in vertebral and femoral bone density following therapy with estradiol and estradiol and testosterone implants. Obstet Gynecol. 1992;79:968–972
  5. Utian WH. The true clinical features of postmenopausal oophorectomy and their response to estrogen therapy. S Afr Med J. 1972;46:732–737
  6. Campbell S, Whitehead M. Estrogen therapy and the menopausal syndrome. Clin Obstet Gynecol. 1977;4:31–47
  7. Van Keep PA, Gregory A. Sexual relations in the ageing female. In:  Money J,  Musaph H editor. Handbook of Sexology. Amsterdam: Excerpta Medica; 1977;
  8. Maoz B, Durst N. The effects of estrogen therapy on the sex life in postmenopausal women. Maturitas. 1980;2:327–336
  9. Studd JWW, Chakravarti S, Oram D. The Climacteric. Clin Obstet Gynecol. 1977;4:3–29
  10. Studd JWW, Collins WP, Chakravarti S, et al. Estradiol and testosterone implants in the treatment of psychosexual problems in the postmenopausal woman. Br J Obstet Gynecol. 1977;84:314–320
  11. Burger HG, Hailes J, Menelaus M, et al. The management of persistent symptoms with estradiol-testosterone implants: clinical, lipid and hormonal results. Maturitas. 1984;6:351–358
  12. Burger HG, Hailes J, Nelson J, Menelaus M. Effect of combined implants of estradiol and testosterone on libido in postmenopausal women. Br Med J. 1987;294:936–937
  13. Dow MGT, Hart DM, Forrest CA. Hormonal treatment of sexual unresponsiveness in postmenopausal women. Br J Obstet Gynecol. 1983;90:361–366
  14. The Geigy Tables, Scientific Tables for Randomisation, 8th Ed. pp 167, Ciba Geigy, Switzerland.
  15. Mazess RB, Barden HS, Bisek JP, Hansen J. Dual energy X-ray absorptiometry for total body and regional bone mineral soft tissue component. Am J Clin Nutr. 1990;51:1106–1112
  16. Mazess R, Collick B, Trempe J, et al. Performance evaluation of a dual-energy X-ray bone densitometer. Calcif Tissue Int. 1989;44:228–232
  17. Durnin JV, Womersley GA. Body fat assessment from total body density and its estimation from skin fold thicknesses; measurements of 481 men and women aged from 16 to 72 years. Br J Nutr. 1974;33:77–97
  18. Lukaski HC, Bolonchuck WW, Hall CB, Sider WA. Validation of tetrapolar bioelectrical impedance method to assess human body composition. J Appl Physiol. 1986;60:1327–1332
  19. Fedor-Freybergh P. The influence of estrogens on the well-being and mental performance in climacteric and postmenopausal women. Sweden: Ka-Ve Tryck A.B.; 1977;
  20. Burger HG, Yamada Y, Bangah ML, McCloud PJ, Wame GL. Serum gonadotropin, sex steroid and immunoreactive inhibin levels in the first 2 years of life. J Clin Endocrinol Metab. 1991;72:682–686
  21. Friedwald WT, Levy RJ, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499–509
  22. Altman DG. Comparability of randomised groups. The Statistician. 1985;34:125–136
  23. Lavori PW, Louis TA, Bailar JC, Polansky M. Designs for experiments — parallel comparisons of treatment. N Eng J Med. 1983;309:1291–1298
  24. Buchanan JR, Hodspodar P, Myers C, Leuenberger P, Demers LM. Effect of excess endogenous androgens on bone density in young women. J Clin Endocrinol Metab. 1988;67:937–943
  25. Steinberg KK, Freni-Titulaer LW, De Puey GEG, et al. Sex steroids and bone density in premenopausal and perimenopausal women. J Clin Endocrinol Metab. 1989;69:533–539
  26. Wild RA, Buchanan JR, Myers C, Demers LM. Deciining adrenal androgens: an association with bone loss in ageing women. Proc Sot Exp Biol Med. 1987;186:355–360
  27. Colvard DS, Ericksen EF, Keeting PE, et al. Identification of androgen receptors in normal human ostoblast-like cells. Proc Nat1 Acad Sci USA. 1989;86:854–857
  28. Kasperk CH, Wergedal JE, Farley JR, Linkarkta , Twiner RJ, Baylink DJ. Androgens directly stimulate proliferation of bone ceils in vitro. Endocrinology. 1989;124:1576–1578
  29. Farish E, Fletcher CD, Hart DM, et al. The effects of hormone implants on serum lipoproteins and steroid hormones in bilateral oophorectomised women. Acta Endocrinol. 1984;106:116–120

☆ Reprint of an article originally published in Maturitas, 21(3), pp. 227–236.

☆☆ Presented at the 7th International Congress on the Menopause; Stockholm, Sweden, June 20–24, 1993 — Abstract Nos. 49 & 432.

PII: S0378-5122(08)00223-5

doi: 10.1016/j.maturitas.2008.09.006

Maturitas
Volume 61, Issue 1 , Pages 17-26 , September 2008

Article Tools